Anti-epileptogenic Effects of Eslicarbazepine Acetate

Clinical trial NCT06597084 · COMPLETED

Trial details

NCT number: NCT06597084
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Post Stroke Epilepsy

Start date: 2019-05-29
Primary completion: 2023-09-11
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.